NASDAQ: VAXX - Vaxxinity, Inc.

छह महीने के लिए लाभप्रदता: -99.93%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Vaxxinity, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Vaxxinity, Inc.

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

अधिक जानकारी
The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and VXX-301, an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; VXX-401 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Merritt Island, Florida.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2021-11-11
ISIN US92244V1044
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.vaxxinity.com
Цена ао 0.65
प्रति दिन मूल्य परिवर्तन: -33.33% (0.0003)
प्रति सप्ताह मूल्य परिवर्तन: -33.33% (0.0003)
प्रति माह मूल्य परिवर्तन: +100% (0.0001)
3 महीने में कीमत में बदलाव: -99% (0.02)
छह महीने में कीमत में बदलाव: -99.93% (0.2739)
प्रति वर्ष मूल्य परिवर्तन: -99.98% (0.85)
3 वर्षों में मूल्य परिवर्तन: -100% (6.56)
5 वर्षों में मूल्य परिवर्तन: 0% (0.0002)
10 वर्षों में मूल्य परिवर्तन: 0% (0.0002)
वर्ष की शुरुआत से मूल्य परिवर्तन: -90% (0.002)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 9.72 1
P/E 0 0
EV/EBITDA -2.51 0
कुल: 2.63

क्षमता

नाम अर्थ श्रेणी
ROA, % -128.37 0
ROE, % -424.6 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.2706 10
कुल: 9.6

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -100.18 0
लाभप्रदता Ebitda, % -99.59 0
लाभप्रदता EPS, % 294.77 10
कुल: 4
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Prime Movers Lab, LLC 15744167 13.95
Adage Capital Partners GP L.L.C. 3000000 2.66
Blackrock Inc. 2526951 2.24
Vanguard Group Inc 2377385 2.11
State Street Corporation 832473 0.74
Geode Capital Management, LLC 829802 0.74
Bank of America Corporation 499557 0.44
Northern Trust Corporation 351812 0.31
Creative Planning 278646 0.25
Pathstone Family Office, LLC 153846 0.14



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Louis Garfield Reese IV Co-Founder & Executive Chairman of the Board 83.28k 1982 (43 वर्ष)
Ms. Mei Mei Hu J.D. Co-Founder, President, CEO & Director 551.73k 1983 (42 वर्ष)
Mr. Jason Pesile CPA, M.B.A. Chief Accounting Officer N/A 1973 (52 वर्ष)
Ms. Sumita Ray J.D. Chief Legal, Compliance & Administrative Officer and Corporate Secretary N/A 1974 (51 वर्ष)
Mr. Mark Joinnides MSE Chief of Staff N/A
Dr. Jean-Cosme Dodart Ph.D. Chief Scientific Officer N/A
Dr. Manal Morsy M.B.A., M.D., PH.D. Chief Regulatory Officer

पता: United States, Merritt Island. FL, 505 Odyssey Way - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.vaxxinity.com